Yanxi Peng

1.1k total citations
10 papers, 633 citations indexed

About

Yanxi Peng is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yanxi Peng has authored 10 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Yanxi Peng's work include RNA modifications and cancer (7 papers), Cancer-related gene regulation (6 papers) and Epigenetics and DNA Methylation (4 papers). Yanxi Peng is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related gene regulation (6 papers) and Epigenetics and DNA Methylation (4 papers). Yanxi Peng collaborates with scholars based in China, United States and Norway. Yanxi Peng's co-authors include Zhuojia Chen, Jiexin Li, Hongsheng Wang, Feng Chen, Zihan Li, Jian Tu, Shuibin Lin, Yu‐Yi Ling, Cheng-Ming Chiang and Guoyou Xie and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yanxi Peng

8 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yanxi Peng China	7	565	256	65	61	31	10	633
Hideki Terajima Japan	8	383 0.7×	115 0.4×	27 0.4×	23 0.4×	18 0.6×	8	498
Xiaoge Hu China	13	445 0.8×	340 1.3×	123 1.9×	29 0.5×	18 0.6×	26	596
Scott Smemo United States	7	718 1.3×	182 0.7×	37 0.6×	60 1.0×	26 0.8×	8	833
Gregory S. McElroy United States	10	422 0.7×	176 0.7×	31 0.5×	11 0.2×	31 1.0×	12	577
P Groza Slovakia	6	615 1.1×	248 1.0×	44 0.7×	41 0.7×	11 0.4×	40	711
Katherina M. Alsina United States	14	454 0.8×	58 0.2×	33 0.5×	14 0.2×	55 1.8×	23	648
Jinlin Du China	11	237 0.4×	140 0.5×	73 1.1×	10 0.2×	23 0.7×	19	344
Hsiang‐Ting Ho United States	14	521 0.9×	146 0.6×	11 0.2×	20 0.3×	86 2.8×	19	674
Hwee Won Ji South Korea	8	207 0.4×	74 0.3×	42 0.6×	14 0.2×	109 3.5×	9	425

Countries citing papers authored by Yanxi Peng

Since Specialization

Citations

This map shows the geographic impact of Yanxi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxi Peng more than expected).

Fields of papers citing papers by Yanxi Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanxi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxi Peng. The network helps show where Yanxi Peng may publish in the future.

Co-authorship network of co-authors of Yanxi Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yanxi Peng. A scholar is included among the top collaborators of Yanxi Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanxi Peng. Yanxi Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Zhang, Haisheng, Linlin Lu, Yi Cheng, et al.. (2025). BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression. Acta Pharmaceutica Sinica B. 15(3). 1552–1570. 1 indexed citations

Peng, Yanxi, et al.. (2025). N6-Methyladenosine Promotes the Transcription of c-Src Kinase via IRF1 to Facilitate the Proliferation of Liver Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(7). 1679–1693.

Peng, Jianxin, Jiawang Zhou, Weifeng Yang, et al.. (2025). N6-methyladenosine attenuates tumor-associated macrophages M2 polarization via suppressing the translation of Snail. Science China Life Sciences. 69(1). 119–135.

Li, Jiexin, Zhuojia Chen, Feng Chen, et al.. (2020). Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Research. 48(10). 5684–5694. 185 indexed citations

Li, Zihan, Yanxi Peng, Jiexin Li, et al.. (2020). N6-methyladenosine regulates glycolysis of cancer cells through PDK4. Nature Communications. 11(1). 2578–2578. 233 indexed citations

An, Panpan, Feng Chen, Zihan Li, et al.. (2020). HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals. Oncogene. 39(26). 4956–4969. 49 indexed citations

Li, Jiexin, et al.. (2020). N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial–Mesenchymal Transition of Cancer Cells. Cells. 9(2). 296–296. 47 indexed citations

Chen, Zhuojia, Long Wu, Jiawang Zhou, et al.. (2020). N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming. Theranostics. 10(8). 3382–3396. 57 indexed citations

Zhang, Wenping, Yuqiang Shi, Yanxi Peng, et al.. (2018). Neuron activity–induced Wnt signaling up-regulates expression of brain-derived neurotrophic factor in the pain neural circuit. Journal of Biological Chemistry. 293(40). 15641–15651. 51 indexed citations

10.

Peng, Yanxi, et al.. (2012). A Role of the Mammalian Target of Rapamycin (mTOR) in Glutamate-Induced Down-regulation of Tuberous Sclerosis Complex Proteins 2 (TSC2). Journal of Molecular Neuroscience. 47(2). 340–345. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact